Related Experiment Video

Updated: Sep 27, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret

Laura Cerchia1, Domenico Libri, Maria Stella Carlomagno

  • 1Istituto per l'Endocrinologia e l'Oncologia Sperimentale del CNR G. Salvatore, via Pansini 5, 80131 Napoli, Italy.

The Biochemical Journal
|March 13, 2003
PubMed

Insights

A Ret receptor mutation causes dimerization and activation. A purified mutant protein (EC-Ret(C634Y)) inhibits this dimerization and competes for ligand binding, offering insights into MEN2A tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The Ret tyrosine kinase receptor plays a crucial role in cell signaling.
  • Mutations in Ret, particularly at Cys-634, lead to receptor dimerization and activation, driving oncogenesis.
  • Understanding the molecular mechanisms of Ret activation is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the molecular basis of Ret receptor activation by Cys-634 substitution.
  • To characterize a purified mutant Ret ectodomain protein (EC-Ret(C634Y)).
  • To explore the potential of EC-Ret(C634Y) as a tool for developing molecular mimetics against Ret mutations.

Main Methods:

  • Purification of a glycosylated, biologically active mutant Ret ectodomain (EC-Ret(C634Y)).
  • Utilizing an in vitro cell system to assess the inhibitory effects of EC-Ret(C634Y) on membrane-bound Ret(C634Y).
  • Evaluating the competition of EC-Ret(C634Y) with wild-type Ret for ligand binding.

Main Results:

  • EC-Ret(C634Y) was successfully purified and confirmed to be glycosylated and biologically active.
  • EC-Ret(C634Y) demonstrated inhibitory activity against the membrane-bound Ret(C634Y) receptor, preventing its dimerization.
  • EC-Ret(C634Y) was shown to compete with the wild-type Ret receptor for ligand binding.

Conclusions:

  • The study provides molecular insights into Ret receptor activation mechanisms.
  • EC-Ret(C634Y) can inhibit Ret dimerization and ligand binding, suggesting its potential therapeutic relevance.
  • This research offers a valuable tool for developing targeted therapies for multiple endocrine neoplasia type 2A (MEN2A) and other Ret-driven cancers.

More Related Videos

A Method to Study de novo Formation of Chromatin Domains00:07

A Method to Study de novo Formation of Chromatin Domains

Published on: August 23, 2019

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...